Donohoe G - Search Results

1

Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium.

van Erp TG, Hibar DP, Rasmussen JM, Glahn DC, Pearlson GD, Andreassen OA, Agartz I, Westlye LT, Haukvik UK, Dale AM, Melle I, Hartberg CB, Gruber O, Kraemer B, Zilles D, Donohoe G, Kelly S, McDonald C, Morris DW, Cannon DM, Corvin A, Machielsen MW, Koenders L, de Haan L, Veltman DJ, Satterthwaite TD, Wolf DH, Gur RC, Gur RE, Potkin SG, Mathalon DH, Mueller BA, Preda A, Macciardi F, Ehrlich S, Walton E, Hass J, Calhoun VD, Bockholt HJ, Sponheim SR, Shoemaker JM, van Haren NE, Hulshoff Pol HE, Ophoff RA, Kahn RS, Roiz-Santiañez R, Crespo-Facorro B, Wang L, Alpert KI, Jönsson EG, Dimitrova R, Bois C, Whalley HC, McIntosh AM, Lawrie SM, Hashimoto R, Thompson PM, Turner JA. van Erp TG, et al. Among authors: donohoe g. Mol Psychiatry. 2016 Apr;21(4):547-53. doi: 10.1038/mp.2015.63. Epub 2015 Jun 2. Mol Psychiatry. 2016. PMID: 26033243 Free PMC article.

2

Investigation of the apolipoprotein-L (APOL) gene family and schizophrenia using a novel DNA pooling strategy for public database SNPs.

McGhee KA, Morris DW, Schwaiger S, Nangle JM, Donohoe G, Clarke S, Meagher D, Quinn J, Scully P, Waddington JL, Gill M, Corvin A. McGhee KA, et al. Among authors: donohoe g. Schizophr Res. 2005 Jul 15;76(2-3):231-8. doi: 10.1016/j.schres.2005.01.006. Schizophr Res. 2005. PMID: 15949655

3

Are the cognitive deficits associated with impaired insight in schizophrenia specific to executive task performance?

Donohoe G, Corvin A, Robertson IH. Donohoe G, et al. J Nerv Ment Dis. 2005 Dec;193(12):803-8. doi: 10.1097/01.nmd.0000190587.01950.72. J Nerv Ment Dis. 2005. PMID: 16319702 Review.

4

Evidence that specific executive functions predict symptom variance among schizophrenia patients with a predominantly negative symptom profile.

Donohoe G, Corvin A, Robertson IH. Donohoe G, et al. Cogn Neuropsychiatry. 2006 Jan;11(1):13-32. doi: 10.1080/13546800444000155. Cogn Neuropsychiatry. 2006. PMID: 16537231 Clinical Trial.

5

Neurocognition and suicidal behaviour in an Irish population with major psychotic disorders.

Nangle JM, Clarke S, Morris DW, Schwaiger S, McGhee KA, Kenny N, Murphy K, Gill M, Corvin A, Donohoe G. Nangle JM, et al. Among authors: donohoe g. Schizophr Res. 2006 Jul;85(1-3):196-200. doi: 10.1016/j.schres.2006.03.035. Epub 2006 May 9. Schizophr Res. 2006. PMID: 16690256

6

Are deficits in executive sub-processes simply reflecting more general cognitive decline in schizophrenia?

Donohoe G, Clarke S, Morris D, Nangle JM, Schwaiger S, Gill M, Corvin A, Robertson IH. Donohoe G, et al. Schizophr Res. 2006 Jul;85(1-3):168-73. doi: 10.1016/j.schres.2006.03.041. Epub 2006 May 23. Schizophr Res. 2006. PMID: 16716568

7

Variance in neurocognitive performance is associated with dysbindin-1 in schizophrenia: a preliminary study.

Donohoe G, Morris DW, Clarke S, McGhee KA, Schwaiger S, Nangle JM, Garavan H, Robertson IH, Gill M, Corvin A. Donohoe G, et al. Neuropsychologia. 2007 Jan 28;45(2):454-8. doi: 10.1016/j.neuropsychologia.2006.06.016. Epub 2006 Aug 22. Neuropsychologia. 2007. PMID: 16930638

8

Do antisaccade deficits in schizophrenia provide evidence of a specific inhibitory function?

Donohoe G, Reilly R, Clarke S, Meredith S, Green B, Morris D, Gill M, Corvin A, Garavan H, Robertson IH. Donohoe G, et al. J Int Neuropsychol Soc. 2006 Nov;12(6):901-6. doi: 10.1017/S135561770606108X. J Int Neuropsychol Soc. 2006. PMID: 17064452

9

Evidence for association and epistasis at the DAOA/G30 and D-amino acid oxidase loci in an Irish schizophrenia sample.

Corvin A, McGhee KA, Murphy K, Donohoe G, Nangle JM, Schwaiger S, Kenny N, Clarke S, Meagher D, Quinn J, Scully P, Baldwin P, Browne D, Walsh C, Waddington JL, Morris DW, Gill M. Corvin A, et al. Among authors: donohoe g. Am J Med Genet B Neuropsychiatr Genet. 2007 Oct 5;144B(7):949-53. doi: 10.1002/ajmg.b.30452. Am J Med Genet B Neuropsychiatr Genet. 2007. PMID: 17492767

10

Dysbindin (DTNBP1) and the biogenesis of lysosome-related organelles complex 1 (BLOC-1): main and epistatic gene effects are potential contributors to schizophrenia susceptibility.

Morris DW, Murphy K, Kenny N, Purcell SM, McGhee KA, Schwaiger S, Nangle JM, Donohoe G, Clarke S, Scully P, Quinn J, Meagher D, Baldwin P, Crumlish N, O'Callaghan E, Waddington JL, Gill M, Corvin AP. Morris DW, et al. Among authors: donohoe g. Biol Psychiatry. 2008 Jan 1;63(1):24-31. doi: 10.1016/j.biopsych.2006.12.025. Epub 2007 Jul 9. Biol Psychiatry. 2008. PMID: 17618940

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

303 results

Search Page